The percentage of CD14++CD16- cells is significantly higher in patients with post-MI arrhythmias (81.84 ± 0.97%) than MI patients without arrhythmias (70.18 ± 1.88%, p=0.047) and controls (61.76± 5.00%, p<0.001). This evidence concerns the gene CD14 and cardiac arrhythmia.